Cardinal Health (CAH) Scheduled to Post Quarterly Earnings on Thursday

Cardinal Health (NYSE:CAH) will announce its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $1.96 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion during the quarter, compared to analysts’ expectations of $57.02 billion. During the same quarter in the prior year, the business posted $1.32 earnings per share. The business’s quarterly revenue was up 11.6% on a year-over-year basis. On average, analysts expect Cardinal Health to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cardinal Health Trading Up 0.1 %

NYSE CAH opened at $103.03 on Wednesday. The stock has a market cap of $25.06 billion, a price-to-earnings ratio of 40.57, a PEG ratio of 1.04 and a beta of 0.68. Cardinal Health has a 12 month low of $77.56 and a 12 month high of $116.04. The company’s 50 day moving average is $109.48 and its two-hundred day moving average is $104.93.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 1.94%. Cardinal Health’s dividend payout ratio is presently 78.74%.

Analyst Ratings Changes

CAH has been the topic of several analyst reports. UBS Group boosted their price objective on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. SVB Leerink began coverage on shares of Cardinal Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $125.00 price objective for the company. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, April 24th. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. Finally, Wells Fargo & Company cut their target price on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research note on Monday. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $102.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.